Medline (MDLN) Net Income towards Common Stockholders (2025 - 2026)
Medline (MDLN) reported Net Income towards Common Stockholders of $239.0 million for Q1 2026, down 25.78% year-over-year from $322.0 million in Q1 2025, and down 25.78% on a QoQ basis from $322.0 million in Q1 2025.
Medline (MDLN) has 2 years of Net Income towards Common Stockholders data on file, last reported at $239.0 million in Q1 2026.
- Quarterly Net Income towards Common Stockholders fell 25.78% year-over-year to $239.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $561.0 million (changed N/A YoY) and the FY2025 annual result came in at $1.2 billion, down 3.58% from the prior year.
- Net Income towards Common Stockholders slipped to $239.0 million in Q1 2026 per MDLN's latest filing, from $322.0 million in the prior quarter.
- Across five years, Net Income towards Common Stockholders topped out at $322.0 million in Q1 2025 and bottomed at $239.0 million in Q1 2026.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 146.28 Bn | 141.88 Bn | 1.83 Bn | 826.00 Mn |
| 2 | Becton Dickinson | 41.14 Bn | 40.13 Bn | 2.15 Bn | -274.00 Mn |
| 3 | Medline | 29.16 Bn | 35.00 Bn | 1.84 Bn | 239.00 Mn |
| 4 | Resmed | 27.13 Bn | 25.47 Bn | 890.98 Mn | 398.73 Mn |
| 5 | West Pharmaceutical Services | 22.71 Bn | 22.19 Bn | 296.40 Mn | 135.40 Mn |
| 6 | Solventum | 13.26 Bn | 13.26 Bn | 1.10 Bn | 13.00 Mn |
| 7 | Align Technology | 12.22 Bn | 11.16 Bn | 736.59 Mn | 112.77 Mn |
| 8 | Cooper Companies | 11.79 Bn | 11.66 Bn | 695.20 Mn | 130.80 Mn |
| 9 | Baxter International | 9.47 Bn | 7.42 Bn | 891.00 Mn | 2.00 Mn |
| 10 | Aptargroup | 7.19 Bn | 6.99 Bn | 351.91 Mn | 72.77 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 28, 2026 | 239.00 Mn |
| Mar 29, 2025 | 322.00 Mn |